(19)
(11) EP 3 544 972 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
07.06.2023 Bulletin 2023/23

(45) Mention of the grant of the patent:
26.04.2023 Bulletin 2023/17

(21) Application number: 17818281.2

(22) Date of filing: 27.11.2017
(51) International Patent Classification (IPC): 
C07D 403/04(2006.01)
C07D 417/04(2006.01)
A61K 31/433(2006.01)
A61P 25/00(2006.01)
 C07D 413/04(2006.01)
A61K 31/4155(2006.01)
A61K 31/5375(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 25/00; C07D 231/20; C07D 403/04; C07D 413/04; C07D 417/04
(86) International application number:
PCT/IB2017/057418
(87) International publication number:
WO 2018/096510 (31.05.2018 Gazette 2018/22)

(54)

HETEROARYLPHENOXY BENZAMIDE KAPPA OPIOID LIGANDS

HETEROARYLPHENOXY-BENZAMID KAPPA OPIOID LIGANDEN

LIGANDS OPIOÏDES KAPPA HÉTÉROARYLPHÉNOXY BENZAMIDE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 28.11.2016 US 201662426980 P
24.10.2017 US 201762576435 P
13.11.2017 US 201762585016 P

(43) Date of publication of application:
02.10.2019 Bulletin 2019/40

(73) Proprietor: Pfizer Inc.
New York, NY 10001-2192 (US)

(72) Inventors:
  • ARORA, Kapildev Kashmirilal
    Niantic, Connecticut 06357 (US)
  • BRODNEY, Michael Aaron
    Newton, Massachusetts 02461 (US)
  • DUNN, Matthew Francis
    Middletown, Connecticut 06457 (US)
  • GREEN, Michael Eric
    Boston, Massachusetts 02127 (US)
  • KABLAOUI, Natasha Mariam
    Newton, MA 02458 (US)
  • KAUFFMAN, Gregory Wayne
    East Greenwich, Rhode Island 02818 (US)
  • MENTE, Scot Richard
    Arlington, Massachusetts 02476 (US)
  • MONTGOMERY, Justin Ian
    Ledyard, Connecticut 06339 (US)
  • RANKIC, Danica Antonia
    New London, Connecticut 06320 (US)
  • ROGERS, Bruce Nelsen
    Belmont, Massachusetts 02478 (US)
  • VERHOEST, Patrick Robert
    Newton, Massachusetts 02460 (US)

(74) Representative: Cohausz & Florack 
Patent- & Rechtsanwälte Partnerschaftsgesellschaft mbB Bleichstraße 14
40211 Düsseldorf
40211 Düsseldorf (DE)


(56) References cited: : 
EP-A1- 1 132 379
 US-A1- 2009 186 873
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).